DiscoverAnswers from the LabQuantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.
Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

Update: 2025-06-17
Share

Description

Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.

(01:14 )
Could you give us a brief overview of this assay?

 

(02:06 )
Can you explain the differences of the qualitative and quantitative methods and why we made the change to a quantitative adenovirus method?

 

(04:00 )
When is this test typically ordered for transplant patients? Is it used throughout their treatment?

 

(06:56 )

Could an immunocompromised person be unknowingly infected?

 

(07:31 )

Is our quantitative method approved for pediatric patients?

 

(08:00 )

How are the test results used to treat patients?


(10:36 )

What other infections might providers consider alongside adeovirus?

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

Mayo Clinic Laboratories